UBS AM’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,173
Closed -$115K 2771
2022
Q1
$115K Hold
1,173
﹤0.01% 2730
2021
Q4
$192K Sell
1,173
-680
-37% -$111K ﹤0.01% 2769
2021
Q3
$506K Hold
1,853
﹤0.01% 2498
2021
Q2
$734K Buy
1,853
+334
+22% +$132K ﹤0.01% 2370
2021
Q1
$820K Buy
1,519
+231
+18% +$125K ﹤0.01% 2178
2020
Q4
$487K Hold
1,288
﹤0.01% 2309
2020
Q3
$487K Sell
1,288
-28
-2% -$10.6K ﹤0.01% 2155
2020
Q2
$648K Buy
1,316
+260
+25% +$128K ﹤0.01% 2004
2020
Q1
$388K Buy
1,056
+127
+14% +$46.7K ﹤0.01% 2070
2019
Q4
$658K Buy
929
+284
+44% +$201K ﹤0.01% 2116
2019
Q3
$414K Buy
645
+43
+7% +$27.6K ﹤0.01% 2361
2019
Q2
$526K Sell
602
-79
-12% -$69K ﹤0.01% 2186
2019
Q1
$393K Buy
681
+45
+7% +$26K ﹤0.01% 2204
2018
Q4
$179K Buy
636
+186
+41% +$52.2K ﹤0.01% 2420
2018
Q3
$216K Hold
450
﹤0.01% 2412
2018
Q2
$204K Sell
450
-77
-15% -$34.9K ﹤0.01% 2471
2018
Q1
$310K Buy
527
+99
+23% +$58.3K ﹤0.01% 2195
2017
Q4
$265K Buy
428
+59
+16% +$36.6K ﹤0.01% 2175
2017
Q3
$340K Buy
369
+118
+47% +$109K ﹤0.01% 2041
2017
Q2
$234K Hold
251
﹤0.01% 2143
2017
Q1
$239K Buy
251
+111
+79% +$106K ﹤0.01% 2098
2016
Q4
$112K Sell
140
-231
-62% -$185K ﹤0.01% 2235
2016
Q3
$313K Hold
371
﹤0.01% 2244
2016
Q2
$305K Sell
371
-99
-21% -$81.4K ﹤0.01% 2216
2016
Q1
$523K Sell
470
-159
-25% -$177K ﹤0.01% 1898
2015
Q4
$783K Buy
629
+278
+79% +$346K ﹤0.01% 1838
2015
Q3
$475K Sell
351
-23
-6% -$31.1K ﹤0.01% 2046
2015
Q2
$673K Buy
374
+90
+32% +$162K ﹤0.01% 1887
2015
Q1
$459K Buy
284
+28
+11% +$45.3K ﹤0.01% 2020
2014
Q4
$195K Hold
256
﹤0.01% 2477
2014
Q3
$101K Hold
256
﹤0.01% 2513
2014
Q2
$155K Hold
256
﹤0.01% 2466
2014
Q1
$176K Hold
256
﹤0.01% 2451
2013
Q4
$167K Buy
+256
New +$167K ﹤0.01% 2415